Cartesian Therapeutics, Inc.
RNAC
Hisse Senetlerindeki Sıralama
#18194
Cartesian Therapeutics, Inc., a clinical-stage biotechnology company, provides... Cartesian Therapeutics, Inc., a clinical-stage biotechnology company, provides mRNA cell therapies for the treatment of autoimmune diseases. The company’s lead product candidate is Descartes-08, an autologous mRNA chimeric antigen receptor T-cell cell therapy (CAR-T) directed against the B cell maturation antigen (BCMA), which is in Phase 2b clinical trials for the treatment of autoimmune diseases, generalized myasthenia gravis, and systemic lupus erythematosus, as well as rare pediatric disease designation for the treatment of juvenile dermatomyositis. It is also developing Descartes-15, which is in phase 1 trials, an autologous autologous B cell maturation antigen (BCMA) directed mRNA CAR-T to treat patients with multiple myeloma. The company is headquartered in Frederick, Maryland.
Hisse Fiyatı
$6.44
Son senkronizasyon: 2026-10-21
Piyasa Değeri
$194.84M
Değişim (1 gün)
0.70%
Değişim (1 yıl)
865.08%
Ülke
US
Ticaret Cartesian Therapeutics, Inc. (RNAC)
Kategori
Healthcare
Cartesian Therapeutics, Inc. (RNAC) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $0.79 - 2023-12-01
Gün sonu en düşük fiyat: $14.00 - 2016-06-01
Gün sonu en düşük fiyat: $14.00 - 2016-06-01
Cartesian Therapeutics, Inc. için hisse fiyatı geçmişi: 2016 - 2026
Yıllık Hisse Fiyatı Performansı
| Yıl | Performans |
|---|---|
| 2023 | -33.64% |
| 2022 | -62.77% |
| 2021 | 0.01% |
| 2020 | 73.71% |
| 2019 | -58.81% |
| 2018 | -55.20% |
| 2017 | -51.08% |
| 2016 | 0.00% |
Benzer şirketler veya rakiplerin hisse fiyatı
| Şirket | Hisse fiyatı | Değişim 1yıl% | Ülke |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $136.29 | -4.85% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $752.87 | 7.01% |
CH
|
